您的位置: 首页 > 农业专利 > 详情页

Therapy targeting Cathepsin S
专利权人:
FUSION ANTIBODIES LIMITED
发明人:
SCOTT, CHRISTOPHER,BURDEN, ROBERTA,OLWILL, SHANE,GORMLEY, JULIE,THOMAS, JAQUIN,MCMEEL, DARRAGH,JOHNSTON, JAMES
申请号:
NZ57198507
公开号:
NZ571985A
申请日:
2007.04.10
申请国别(地区):
NZ
年份:
2012
代理人:
摘要:
Disclosed is an antibody molecule or a nucleic acid encoding said antibody molecule, wherein said antibody molecule specifically binds Cathepsin S but does not inhibit the proteolytic activity of Cathepsin S and wherein said anti-Cathepsin S antibody molecule is: (i) capable of inducing ADCC or (ii) comprised in an immunoconjugate of an anti-Cathepsin antibody molecule and a chemotherapeutic agent or (iii) capable of sequestering Cathepsin S. Also disclosed is the use of said antibody molecule in the preparation of a medicament for the treatment of neoplastic disease, cancer, inflammatory condition, or an ocular disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充